Acquirers have warmed up to medical technology companies, allured by predictable businesses and lower risk.
By the numbers: With a few large deals pacing the quarter, medtech M&A totaled $26.6 billion across 38 deals in Q1, compared to $8.3 billion across 51 deals in the same period last year, according to a report from JP Morgan.
